Butyrolactone: more than a kinase inhibitor?

Cell Cycle. Mar-Apr 2002;1(2):117-8. doi: 10.4161/cc.1.2.114.
No abstract available

Publication types

  • Review
  • Comment

MeSH terms

  • Animals
  • Butyrophenones / pharmacology*
  • CDC2 Protein Kinase / antagonists & inhibitors
  • CDC2-CDC28 Kinases*
  • Cell Cycle
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclin-Dependent Kinases / antagonists & inhibitors*
  • Cyclins / metabolism*
  • DNA Damage*
  • Peptide Synthases / metabolism
  • Protein-Serine-Threonine Kinases / antagonists & inhibitors
  • SKP Cullin F-Box Protein Ligases
  • Signal Transduction*
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Butyrophenones
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Tumor Suppressor Protein p53
  • SKP Cullin F-Box Protein Ligases
  • Protein-Serine-Threonine Kinases
  • CDC2 Protein Kinase
  • CDC2-CDC28 Kinases
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinases
  • Peptide Synthases